Immuno 2026 Day 6 Highlights: Dose Optimization and Better Research Decisions
Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications
EVOLUTE: Enfortumab Vedotin in Older Patients With Advanced Urothelial Carcinoma
Pfizer to Present 45 Abstracts at ESMO 2026, With Data in Breast, Genitourinary, Lung Cancers and Melanoma
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade
Deulorlatinib in ALK-Positive NSCLC: Can Deuteration Improve on Lorlatinib?
A New Era in Cervical Cancer Prevention in Algeria: Integration of HPV Vaccination into the National Immunization Program
The Cancer Research UK Lung Cancer Centre of Excellence Conference 2026 will take place from November 4–6, 2026, at The Midland Hotel in Manchester, United Kingdom. Organized by the Cancer Research UK Lung Cancer Centre of Excellence (CRUK Lung Cancer Centre of Excellence), the conference will bring together leading scientists and clinicians to discuss recent […]
